Oxibetaine

This classification denotes an anti-lipidemic agent with the molecular formula C6H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0WVV18VUI, chemically known as n-(2-hydroxyethyl) n,n-dimethylammonioacetat but generally known as oxibetaine, which bears US NIH Compound Identifier 168886. European Medicines Agency schedules Oxibetaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09522MIG. The term OXIBETAINE is an International Non-Proprietary Name. OXIBETAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxibetaine under HS 29239000 and SITC 51481. As of Q4 2014, OXIBETAINE remains the US FDA Preferred Term for this commodity. Oxibetaine bears US NLM identifiers UMLS ID C1882237 and NCI Concept Code C66263. SMILES: OCC[N](CC(=O)O)(C)C.